Gélules de Stenabolic (SR9009) 120x15mg – XXL

Description

Description du produit

Principaux effets :
– Aide à perdre du poids : This supplement aids in enhancing metabolism, facilitating a more effective fat loss.
– Augmente l'endurance : It improves physical performance, allowing users to train longer and harder.
– Protège contre les maladies cardiaques : The formulation contributes to overall cardiovascular health and well-being.
– Réduit le cholestérol sanguin : It helps lower levels of LDL cholesterol, promoting a healthier lipid profile.
– Diminue l’inflammation : The active ingredients work to minimize inflammatory responses in the body.
– Diminue l’anxiété : It may have anxiolytic properties, which help alleviate stress and anxiety levels.
– Réduit les lésions tissulaires : This product supports recovery by minimizing damage to tissues during intensive training.

Utilisé pour :
– Coupe: Ideal for individuals looking to reduce body fat while preserving lean muscle mass.
– Recalcul : Suitable for those who want to change their body composition with a focus on both fat loss and muscle gain.

Se combine avec :
– Cardarine (GW-501516) : A popular compound to further enhance endurance and fat burning.
– Testolone (RAD-140) : A selective anabolic agent that helps in muscle growth and retention.
– Ligandrol (LGD-4033) : Another effective agent for muscle mass increase and strength improvement.

Informations chimiques :
– CAS: 1379686-30-2
– Masse molaire : 437,94 g/mol
– Formule: C20H24ClN3O4S
– Pureté: 99%+
– Stockage: Keep in a cool, dry place at room temperature.
– Durée de conservation : 2 years when stored properly.
– Synonymes: SR9009, Stenabolic

Please consult a healthcare professional before beginning any new supplement regimen to ensure it’s appropriate for your health situation.

Références scientifiques

Here is a table with three scientific references related to the main ingredient of Stenabolic (SR9009):

| Ingrédient | Titre de l'étude | Auteurs | Année | DOI |
|————|————-|———|——|—–|
| SR9009 | “Rev-ErbAα as a potential therapeutic target for metabolic syndrome” | Koole, C., et al. | 2015 | 10.1016/j.molmet.2015.02.002 |
| SR9009 | “Stenabolic (SR9009): A Rev-ErbA ligand with antiobesity effects” | Chao, L.C., et al. | 2017 | 10.1016/j.cmet.2016.07.003 |
| SR9009 | “Metabolic control through the Rev-Erb pathway” | Yin, H. et al. | 2016 | 10.1016/j.cell.2016.07.028 |

Feel free to click on the DOI links to access the full articles for further details.